1 |
Weijs TJ, Ruurda JP, Broekhuizen ME, Bracco Gartner TCL, van Hillegersberg R. Outcome of a step-up treatment strategy for chyle leakage after esophagectomy. Ann Thorac Surg 2017;104:477-84.
DOI
|
2 |
Chen S, Zhao Y, Chen H. Risk factors of chylothorax after esophagectomy. J Thorac Dis 2019;11:1749-52.
DOI
|
3 |
Gupta R, Singh H, Kalia S, Gupta R, Singh R, Verma GR. Chylothorax after esophagectomy for esophageal cancer: risk factors and management. Indian J Gastroenterol 2015;34:240-4.
DOI
|
4 |
Gronnier C, Trechot B, Duhamel A, et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg 2014;260:764-70.
DOI
|
5 |
Berger AC, Scott WJ, Freedman G, et al. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer. Semin Oncol 2005;32:S16-20.
|
6 |
Miao L, Zhang Y, Hu H, et al. Incidence and management of chylothorax after esophagectomy. Thorac Cancer 2015;6:354-8.
DOI
|
7 |
Ohkura Y, Ueno M, Shindoh J, Iizuka T, Ka H, Udagawa H. Risk factors for postoperative chylothorax after radical subtotal esophagectomy. Ann Surg Oncol 2018;25:2739-46.
DOI
|
8 |
Lin Y, Li Z, Li G, et al. Selective en masse ligation of the thoracic duct to prevent chyle leak after esophagectomy. Ann Thorac Surg 2017;103:1802-7.
DOI
|
9 |
Roh JL, Yoon YH, Park CI. Chyle leakage in patients undergoing thyroidectomy plus central neck dissection for differentiated papillary thyroid carcinoma. Ann Surg Oncol 2008;15:2576-80.
DOI
|
10 |
Lei Y, Feng Y, Zeng B, et al. Effect of prophylactic thoracic duct ligation in reducing the incidence of postoperative chylothorax during esophagectomy: a systematic review and meta-analysis. Thorac Cardiovasc Surg 2018;66:370-5.
DOI
|
11 |
Campisi CC, Boccardo F, Piazza C, Campisi C. Evolution of chylous fistula management after neck dissection. Curr Opin Otolaryngol Head Neck Surg 2013;21:150-6.
DOI
|
12 |
Orgill DP, Bayer LR. Update on negative-pressure wound therapy. Plast Reconstr Surg 2011;127 Suppl 1:105S-115S.
DOI
|
13 |
Kirse DJ, Suen JY, Stern SJ. Phrenic nerve paralysis after doxycycline sclerotherapy for chylous fistula. Otolaryngol Head Neck Surg 1997;116:680-3.
DOI
|
14 |
Kadota H, Kakiuchi Y, Yoshida T. Management of chylous fistula after neck dissection using negative-pressure wound therapy: a preliminary report. Laryngoscope 2012;122:997-9.
DOI
|
15 |
Dorneden A, Olson G, Boyd N. Negative pressure wound therapy (Wound VAC) in the treatment of chylous fistula after neck dissection. Ann Otol Rhinol Laryngol 2019;128:569-74.
DOI
|
16 |
Delaney SW, Shi H, Shokrani A, Sinha UK. Management of chyle leak after head and neck surgery: review of current treatment strategies. Int J Otolaryngol 2017;2017:8362874.
|
17 |
Benedix F, Schulz HU, Scheidbach H, Lippert H, Meyer F. Successful conservative treatment of chylothorax following oesophagectomy: a clinical algorithm. S Afr J Surg 2010;48:86-8.
|
18 |
Knochel JP. Complications of total parenteral nutrition. Kidney Int 1985;27:489-96.
DOI
|
19 |
Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007;32:362-9.
DOI
|
20 |
Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-9.
DOI
|
21 |
Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998;66:253-4.
DOI
|
22 |
Jiang H, Deng XF, Duan CM, et al. Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct. Lymphology 2011;44:21-8.
|
23 |
Swanson MS, Hudson RL, Bhandari N, Sinha UK, Maceri DR, Kokot N. Use of octreotide for the management of chyle fistula following neck dissection. JAMA Otolaryngol Head Neck Surg 2015;141:723-7.
DOI
|
24 |
Touska P, Constantinides VA, Palazzo FF. A rare complication: lymphocele following a re-operative right thyroid lobectomy for multinodular goitre. BMJ Case Rep 2012;2012:bcr0220125747.
|
25 |
Mason PF, Ragoowansi RH, Thorpe JA. Post-thoracotomy chylothorax: a cure in the abdomen? Eur J Cardiothorac Surg 1997;11:567-70.
DOI
|
26 |
Miller JI Jr. Diagnosis and management of chylothorax. Chest Surg Clin N Am 1996;6:139-48.
|
27 |
Selle JG, Snyder WH 3rd, Schreiber JT. Chylothorax: indications for surgery. Ann Surg 1973;177:245-9.
DOI
|
28 |
Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003;75:217-22.
DOI
|
29 |
Guillem P, Billeret V, Houcke ML, Triboulet JP. Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine. Dis Esophagus 1999;12:155-6.
DOI
|
30 |
Belloso A, Saravanan K, de Carpentier J. The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat). Laryngoscope 2006;116:1934-5.
DOI
|
31 |
Toliyat M, Singh K, Sibley RC, Chamarthy M, Kalva SP, Pillai AK. Interventional radiology in the management of thoracic duct injuries: anatomy, techniques and results. Clin Imaging 2017;42:183-92.
DOI
|
32 |
Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg 2002;124:499-502.
DOI
|
33 |
Wurnig PN, Hollaus PH, Ohtsuka T, Flege JB, Wolf RK. Thoracoscopic direct clipping of the thoracic duct for chylopericardium and chylothorax. Ann Thorac Surg 2000;70:1662-5.
DOI
|
34 |
Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010;139:584-89.
DOI
|
35 |
Laslett D, Trerotola SO, Itkin M. Delayed complications following technically successful thoracic duct embolization. J Vasc Interv Radiol 2012;23:76-9.
DOI
|
36 |
Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther 2017;46:816-24.
DOI
|
37 |
Defize IL, Schurink B, Weijs TJ, et al. The anatomy of the thoracic duct at the level of the diaphragm: a cadaver study. Ann Anat 2018;217:47-53.
DOI
|
38 |
Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 2014;260:259-66.
DOI
|
39 |
Seow C, Murray L, McKee RF. Surgical pathology is a predictor of outcome in post-operative lymph leakage. Int J Surg 2010;8:636-8.
DOI
|
40 |
Johnson OW, Chick JF, Chauhan NR, et al. The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol 2016;26:2482-93.
DOI
|
41 |
Zilversmit DB. The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest 1965;44:1610-22.
DOI
|
42 |
Ilczyszyn A, Ridha H, Durrani AJ. Management of chyle leak post neck dissection: a case report and literature review. J Plast Reconstr Aesthet Surg 2011;64:e223-30.
DOI
|
43 |
Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982;36:950-62.
DOI
|
44 |
Lama A, Ferreiro L, Toubes ME, et al. Characteristics of patients with pseudochylothorax: a systematic review. J Thorac Dis 2016;8:2093-101.
DOI
|
45 |
Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 2010;31:743-50.
DOI
|
46 |
Agrawal V, Sahn SA. Lipid pleural effusions. Am J Med Sci 2008;335:16-20.
DOI
|
47 |
Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997;10:1157-62.
DOI
|
48 |
Merigliano S, Molena D, Ruol A, et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg 2000;119:453-7.
DOI
|
49 |
Brown S, Abana CO, Hammad H, et al. Low-dose radiation therapy is an effective treatment for refractory postoperative chylous ascites: a case report. Pract Radiat Oncol 2019;9:153-7.
DOI
|
50 |
Inaba Y, Arai Y, Matsueda K, Aramaki T, Kodera Y. Intractable massive ascites following radical gastrectomy, treatment with local intraperitoneal administration of OK-432 using a unified CT and fluoroscopy system. Australas Radiol 2003;47:465-7.
DOI
|
51 |
Huang Y, Gloviczki P, Duncan AA, et al. Management of refractory chylous ascites with peritoneovenous shunts. J Vasc Surg Venous Lymphat Disord 2017;5:538-46.
DOI
|
52 |
Lutz P, Strunk H, Schild HH, Sauerbruch T. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J Gastroenterol 2013;19:1140-2.
DOI
|
53 |
Matsutani T, Hirakata A, Nomura T, et al. Transabdominal approach for chylorrhea after esophagectomy by using fluorescence navigation with indocyanine green. Case Rep Surg 2014;2014:464017.
|
54 |
Lee YS, Kim BW, Chang HS, Park CS. Factors predisposing to chyle leakage following thyroid cancer surgery without lateral neck dissection. Head Neck 2013;35:1149-52.
DOI
|
55 |
Lorenz K, Abuazab M, Sekulla C, Nguyen-Thanh P, Brauckhoff M, Dralle H. Management of lymph fistulas in thyroid surgery. Langenbecks Arch Surg 2010;395:911-7.
DOI
|
56 |
Dhiwakar M, Nambi GI, Ramanikanth TV. Drain removal and aspiration to treat low output chylous fistula. Eur Arch Otorhinolaryngol 2014;271:561-5.
DOI
|
57 |
Nussenbaum B, Liu JH, Sinard RJ. Systematic management of chyle fistula: the Southwestern experience and review of the literature. Otolaryngol Head Neck Surg 2000;122:31-8.
DOI
|